Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
The Effect of Clostridium butyricum on Gut Microbial Changes and Functional Profiles of Metabolism in High-fat Diet-fed Rats Depending on Age and Sex. β
Go to Publication β
Journal of neurogastroenterology and motility (J Neurogastroenterol Motil ) Vol: 30 Issue 2 Pages: 236-250 Pub: 2024 Apr 30 Epub: Authors Choi SI , Kim N , Choi Y , Nam RH , Jang JY , Cho SY , |
|
|
The Effect of Clostridium butyricum on Gut Microbial Changes and Functional Profiles of Metabolism in High-fat Diet-fed Rats Depending on Age and Sex. β
Go to Publication β
Journal of neurogastroenterology and motility (J Neurogastroenterol Motil ) Vol: 30 Issue 2 Pages: 236-250 Pub: 2024 Apr 30 Epub: Authors Choi SI , Kim N , Choi Y , Nam RH , Jang JY , Cho SY , |
|
|
The Effect of Clostridium butyricum on Gut Microbial Changes and Functional Profiles of Metabolism in High-fat Diet-fed Rats Depending on Age and Sex. β
Go to Publication β
Journal of neurogastroenterology and motility (J Neurogastroenterol Motil ) Vol: 30 Issue 2 Pages: 236-250 Pub: 2024 Apr 30 Epub: Authors Choi SI , Kim N , Choi Y , Nam RH , Jang JY , Cho SY , |
|
|
Effects of compatibility of Clostridium butyricum and Bacillus subtilis on growth performance, lipid metabolism, antioxidant status and cecal microflora of broilers during the starter phase. β
Go to Publication β
Animal bioscience (Anim Biosci ) Vol: 37 Issue 11 Pages: 1933-1944 Pub: 2024 Nov Epub: 2024 Jun 27 Authors Zhao X , Zhuang J , Zhang F , Li H , Yu J , Wang C , Lv T , Li Q , Zhang J , |
|
|
Bacillus coagulans and Clostridium butyricum synergistically alleviate depression in a chronic unpredictable mild stress mouse model through altering gut microbiota and prefrontal cortex gene expression. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1393874 Pub: 2024 Epub: 2024 May 23 Authors Xu J , Zhou L , Chen Z , Wang Y , Xu F , Kuang Q , Zhang Y , Zheng H , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
